News
2024.03.04
On the 4th, Dx&Vx announced its intention to grow into a specialized think tank group that directly supports national medical reform for the transition to Medical reformation. Currently, Dx&Vx is rapidly expanding its business in the digital healthcare sector by patenting and registering numerous foundational technologies related to telemedicine services. Dx&Vx's digital healthcare plan primarily focuses on three aspects △Securing a sustainable looped genome portfolio for continuous data generation.△Providing innovative diagnostic platforms utilizing medical and genomic data. △The non-face-to-face medical service provides a comprehensive and extensive range of services including non-face-to-face medical consultations and advisory services, medication and medical information, and medication matching services, all protected by our patents, making it a holistic and extensive business that is difficult for other companies to implement. Dx&Vx is integrating data sources under the brand Clidex for genome-related functions, enhancing the analysis and predictive models of customers' health status and the health ecology of society. Concurrently constructing the KHUB platform to integrate various medical data. Based on this platform, plan to sequentially launch patient diagnosis services and non-face-to-face medical services utilizing patented artificial intelligence (AI) starting from April this year. Dx&Vx is also accelerating its efforts in AI-driven drug development. Research is currently underway to dramatically shorten the development and clinical validation periods of new drugs through a genome analysis platform utilizing AI technology. To commercialize this, pursuing collaborations and alliances with IT companies, medical institutions, and other avenues, aiming to accelerate revenue growth through stable revenue expansion via licensing agreements and exploring opportunities for business expansion based on technology transfer. In particular, during the latter half of last year, Dx&Vx has been pursuing alliances to promote open collaboration. Currently developing various medical services in partnership with Google Cloud and LG CNS. This marks the first case among domestic pharmaceutical and biotech companies, and it is predicted to become the most robust BT&IT alliance. A representative from Dx&Vx stated, "In alignment with the government's healthcare reform initiatives, we are collaborating to digitize primary healthcare institutions and actively preparing for Healthcare 4.0 for medical resource management." Further emphasized, "In line with the government's institutionalization plans, we are planning to swiftly launch related services in the medical data platform and non-face-to-face medical consultation market. We are building a system to provide a comprehensive digital healthcare service that satisfies not only patients and healthcare professionals but also the government."